<DOC>
	<DOCNO>NCT00913328</DOCNO>
	<brief_summary>Leukotriene receptor antagonist appear posse additive anti-inflammatory effect effect inhale corticosteroid . Hypothesis : Treatment oral montelukast lower dose-response plateau inhale methacholine patient mild moderate persistent asthma treat stable dose inhaled corticosteroid .</brief_summary>
	<brief_title>Effect Add-on Montelukast Inhaled Corticosteroids Airway Responsiveness</brief_title>
	<detailed_description />
	<mesh_term>Asthma</mesh_term>
	<mesh_term>Montelukast</mesh_term>
	<criteria>Nonsmoking adult mild moderate persistent asthma : FEV1 &gt; 70 % pred PD20 methacholine &lt; 3.9 mmol treat least 3 month stable dose inhaled corticosteroid Documented doseresponse plateau inhale methacholine two occasion Males nonpregnant female Asthma medication inhale corticosteroid inhaled b2agonists Viral respiratory tract infection within 3 week prior enrollment</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>June 2009</verification_date>
	<keyword>Asthma</keyword>
	<keyword>Airway responsiveness</keyword>
	<keyword>Dose-response plateau</keyword>
	<keyword>Montelukast</keyword>
	<keyword>Add-on inhale corticosteroid</keyword>
</DOC>